Yot Teerawattananon is a medical doctor and health economist. He found the Thai Ministry of Public Health’s Health Intervention and Technology Assessment Program (HITAP) in 2007. He is also a co-founder of the Asia’s health technology assessment (HTA) network, HTAsiaLink, and the international Decision Support Initiative (iDSI). His works have been used to inform Universal Healthcare Coverage’s benefits package in Thailand and elsewhere across the globe. He and his team have provided capacity building on HTA including health economic evaluation in more than 30 low- and middle-income countries in Asia and Africa. Since 2018, he has been a visiting professor at Saw Swee Hock School of Public Health at National University of Singapore.
During the COVID-19 pandemic, Yot was part of the Thai MOPH Intelligent Unit for COVID-19 response and a member of the review committee for the COVID-19 Stimulus and Relief Packages managing $45 billion budget of the Royal Thai government. He is also part of the WHO Working Group for development of Target Product Profile of COVID-19 vaccine, and the Prioritization Advisory Committee of the WHO R&D Blueprint for Epidemics. Recently, he leads the new Lancet Commission to strengthen the use of epidemiological modelling to inform policy. This work is expected to come out in 2024.